Skip to content
Screener

EBITDA margin at other companies

TFX
TeleflexTFX
12.6%-13.4pp
Boston Scientific logo
Boston ScientificBSX
25.2%+1.6pp
Intuitive Surgical logo
Intuitive SurgicalISRG
29.4%+3.0pp
Apyx Medical Corporation logo
Apyx Medical CorporationAPYX
-44.7%+10.6pp
PDE
Pro-Dex, Inc.PDEX
16.2%-3.9pp
iRadimed logo
iRadimedIRMD
34.1%+2.9pp

Other financials

Income statement

See full
Revenue$94.5M+19.3%
Gross profit$62.4M+20.5%
Operating income-$27.4M-23.4%
Net income-$26.9M-37.2%
EPS (diluted)-$0.47-34.3%

Balance sheet

See full
Cash & equivalents$11.4M-96.3%
Total debt$77.5M-2.4%
Total equity$340.1M-11.9%
Total assets$479.4M-6.6%

Cash flow

See full
Operating cash flow-$19.3M-28.0%
CapEx$3.0M+5.4%
Free cash flow-$22.2M-24.4%

Valuation

See full
Market cap$1.24B-21.2%
Enterprise value$1.31B
P/S3.7×

Profitability

See full
Gross margin64.2%0.0pp
Operating margin-33.9%+0.5pp
Net margin-32.5%+2.2pp
FCF margin-25.2%-4.6pp

Returns & leverage

See full
Return on equity-30.2%+5.2pp
Debt / equity0.2×0.0×
Current ratio6.5×-2.7×

Where this comes from

Calculated from PROCEPT BioRobotics Corporation’s reported figures.

Based on trailing twelve months.

The source filing: PROCEPT BioRobotics Corporation’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 4:14 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001588978-26-000030

FAQ

What is PROCEPT BioRobotics Corporation's EBITDA margin?
PROCEPT BioRobotics Corporation (PRCT) reported EBITDA margin of -31.8% in Q2 2026.
How has PROCEPT BioRobotics Corporation's EBITDA margin changed year-over-year?
PROCEPT BioRobotics Corporation's EBITDA margin decreased by 1.7% year-over-year, from -31.2% to -31.8%.
What is the long-term trend for PROCEPT BioRobotics Corporation's EBITDA margin?
Over 4 years (2021 to 2025), PROCEPT BioRobotics Corporation's EBITDA margin has grown at a -31.9% compound annual growth rate (CAGR), from -147.5% to -31.6%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.

Ask your AI about PROCEPT BioRobotics Corporation's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude